KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - AdjustmentsLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Held-to-maturityShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Bankshares (UBSI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for United Bankshares (UBSI) over the last 15 years, with Q3 2025 value amounting to $2.5 billion.

  • United Bankshares' Cash & Equivalents rose 3195.08% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 3195.08%. This contributed to the annual value of $2.3 billion for FY2024, which is 4336.0% up from last year.
  • Per United Bankshares' latest filing, its Cash & Equivalents stood at $2.5 billion for Q3 2025, which was up 3195.08% from $2.3 billion recorded in Q2 2025.
  • Over the past 5 years, United Bankshares' Cash & Equivalents peaked at $4.0 billion during Q3 2021, and registered a low of $253.4 million during Q4 2022.
  • In the last 5 years, United Bankshares' Cash & Equivalents had a median value of $1.9 billion in 2024 and averaged $2.0 billion.
  • As far as peak fluctuations go, United Bankshares' Cash & Equivalents plummeted by 6637.35% in 2022, and later skyrocketed by 53096.83% in 2023.
  • United Bankshares' Cash & Equivalents (Quarter) stood at $262.1 million in 2021, then fell by 3.3% to $253.4 million in 2022, then surged by 530.97% to $1.6 billion in 2023, then skyrocketed by 43.36% to $2.3 billion in 2024, then increased by 9.88% to $2.5 billion in 2025.
  • Its Cash & Equivalents was $2.5 billion in Q3 2025, compared to $2.3 billion in Q2 2025 and $2.6 billion in Q1 2025.